283
Views
2
CrossRef citations to date
0
Altmetric
Short Reports

Efficacy and safety of tretinoin 0.05% cream to prevent hyperpigmentation during narrowband UV-B phototherapy in patients with facial vitiligo: a randomized clinical trial

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1738-1741 | Received 10 Jun 2020, Accepted 14 Aug 2020, Published online: 10 Sep 2020

References

  • Bae JM, Jung HM, Hong BY, et al. Phototherapy for vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2017;153(7):666–674.
  • Esmat S, Hegazy RA, Shalaby S, et al. Phototherapy and combination therapies for vitiligo. Dermatol Clin. 2017;35(2):171–192.
  • Vaananen A, Hannuksela M. UVB erythema inhibited by topically applied substances. Acta Derm Venereol. 1989;69(1):12–17.
  • AlJasser MI, Altalhab S, Al-Issa A. Custom paper shield to prevent perilesional hyperpigmentation after excimer laser treatment for vitiligo. J Am Acad Dermatol. 2018;79(4):e65–e66.
  • Kligman AM, Grove GL, Hirose R, et al. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2):836–859.
  • Sosa JJ, Currimbhoy SD, Ukoha U, et al. Confetti-like depigmentation: a potential sign of rapidly progressing vitiligo. J Am Acad Dermatol. 2015;73(2):272–275.
  • Bae JM, Oh SH, Kang HY, East Asia Vitiligo Association, et al. Development and validation of the Vitiligo Extent Score for a Target Area (VESTA) to assess the treatment response of a target lesion. Pigment Cell Melanoma Res. 2019;32(2):315–319.
  • Parsad D, Bhatnagar A, De D. Narrowband ultraviolet B for the treatment of vitiligo. Expert Rev Dermatol. 2010;5(4):445–459.
  • Ravnbak MH, Philipsen PA, Wiegell SR, et al. Skin pigmentation kinetics after UVB exposure. Acta Derm Venereol. 2008;88(3):223–228.
  • Orlow SJ, Chakraborty AK, Pawelek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol. 1990;94(4):461–464.
  • Griffiths CE, Finkel LJ, Ditre CM, et al. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol. 1993;129(4):415–421.
  • Gunia-Krzyżak A, Popiol J, Marona H. Melanogenesis inhibitors: strategies for searching for and evaluation of active compounds. Curr Med Chem. 2016;23(31):3548–3574.
  • Rosenthal DS, Roop DR, Huff CA, et al. Changes in photo-aged human skin following topical application of all-trans retinoic acid. J Invest Dermatol. 1990;95(5):510–515.
  • Garmyn M, Young AR, Miller SA. Mechanisms of and variables affecting UVR photoadaptation in human skin. Photochem Photobiol Sci. 2018;17(12):1932–1940.
  • de Gruijl FR. UV adaptation: pigmentation and protection against overexposure. Exp Dermatol. 2017;26(7):557–562.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.